Heather Zelhart
Family · Kankakee, ILNPI 1477925238
Payments from drug & device makers
Across 224 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$872
- Sumitomo Pharma America, Inc.$758
- Bayer$757
- Olympus America Inc.$602
- AbbVie$370
- Urovant Sciences Inc$228
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,68396%
- Education$1704%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 43 | $872 |
| Sumitomo Pharma America, Inc. | 40 | $758 |
| Bayer | 36 | $757 |
| Olympus America Inc. | 14 | $602 |
| AbbVie | 16 | $370 |
| Urovant Sciences Inc | 15 | $228 |
| Pfizer | 8 | $153 |
| Boston Scientific | 5 | $141 |
| AstraZeneca | 6 | $133 |
| Myovant Sciences Inc. | 5 | $94 |
| Progenics Pharmaceuticals, Inc. | 3 | $73 |
| Johnson & Johnson | 4 | $67 |
| Procept Biorobotics Corporation | 1 | $67 |
| Accord Healthcare, Inc. | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $54 |
| Teleflex LLC | 3 | $51 |
| Blue Earth Diagnostics | 2 | $45 |
| Tolmar, Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| Myriad Genetic Laboratories, Inc. | 2 | $38 |
| Convatec Inc. | 2 | $33 |
| Koelis Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Halozyme Inc | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $18 |
| Cardinal Health 414 LLC | 1 | $16 |
How this compares
$4,853 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 71 | $66,047 |
| MyrbetriqMirabegron | 15 | $15,079 |
| Trimethoprim | 21 | $1,565 |
| Tamsulosin Hcl | 27 | $329 |
| Finasteride | 19 | $273 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $210 |
| Cephalexin | 14 | $111 |
| Anastrozole | 25 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $758 | $66,04771 claims |
| Astellas Pharma US IncMyrbetriq | $872 | $15,07915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Kankakee
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.